The IRCM
Research
The Clinic
Studying at IRCM
Core facilities
Conferences
Careers
Molecular Biology of Neural Development
Skip navigation links
Home
Director
Projects
Approaches and models
Publications
Charron Lab: In The News
Team
Lab Photos
Lab Alumni
Contact us


The IRCM > Research > Research divisions > Neurobiologie et développement > Biologie moléculaire du développement neuronal
Home > Molecular Biology of Neural Development
Home > Molecular Biology of Neural Development
Research unit director
Charron Lab 

The brain is composed of billions of neurons that form a complex network. Inappropriate wiring of these neuronal connections has serious consequences for the sensory, motor and cognitive functions of the nervous system. Dr. Charron’s research focuses on neural development and associated pathologies. He is a leader in Sonic hedgehog (Shh) signaling, having identified an axon pathfinding role for Shh and characterized a novel, non-canonical Shh signaling pathway. He has also characterized novel Shh receptors, a discovery that has fundamental implications for many pathologies, such as pediatric brain tumors.

During embryonic development, neurons extend axons, which are guided to their target via attractive and repulsive guidance molecules. We have demonstrated that Shh acts as a chemoattractive molecule for the axons of certain neurons in the spinal cord. One of Dr. Charron’s objectives is to identify and characterize the components of the Shh signalling pathway in axonal guidance. In addition to helping us understand the immense complexity underlying the wiring of the nervous system, this work will help to identify novel strategies to promote the proper guidance and rewiring of axons damaged by neurodegenerative diseases and brain or spinal cord injuries.

Shh is a multi-functional protein and, in addition to guiding axons, it is also a morphogen which stimulates the proliferation of granule cell precursors in the cerebellum. Abnormal regulation of Shh signaling in the cerebellum leads to medulloblastoma, a pediatric cancer of the brain that is the most common solid tumor in children. Dr. Charron’s research focuses on understanding how medulloblastoma forms, in particular which genes may promote or inhibit medulloblastoma tumorigenesis. This work may lead to the development of novel and more effective targeted therapies to treat medulloblastoma, and improve the survival and quality of life of affected patients.

Affiliations of the Laboratory:

McGill University
Department of Medicine, Division of Experimental Medicine
Department of Biology
Department of Anatomy and Cell Biology
Integrated Program in Neuroscience
Program in Neuroengineering

Université de Montréal
Department of Medicine
Program in Molecular Biology
Centre of Excellence in Neuromics of Université de Montréal (CENUM)

Find out more about us on the NeuroTree!

All rights reserved: IRCM 2011_110 avenue des Pins Ouest - Montréal (Québec) H2W 1R7 – Canada
.